NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (NASDAQ: DRUG) today announced compelling preclinical results for...
The Pure Impact VIP™ standalone device represents a major extension of the Pure Impact™ product line and introduces an all-in-one...
Consulting program optimizes partner clinic businesses with implementation of best practices initiatives, including marketing, reimbursement, and patient retentionHORSHAM, Pa., Sept....
NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf...
Totality of data supports potential for isaralgagene civaparvovec as a one-time, durable treatment of the underlying pathology of Fabry disease...
RED BANK, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company dedicated to developing...
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company),...
MORRISVILLE, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Science 37, the leader in expanding patient access to clinical trials, and...
Solution delivers a 50% reduction in time spent drafting mapping specifications, according to internal measurementsRADNOR, Pa., Sept. 04, 2025 (GLOBE...
Data showed sustained improvements across several key measures of visual function, including low luminance visual acuity and microperimetry Laru-zova was...
PRINCETON, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage,...
Global recognition highlights the company’s leadership in quality, member satisfaction and long-term growthORANGE, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) --...
Preclinical data support the potential for improved weight loss and tolerability with once-monthly administration of MBX 4291CARMEL, Ind., Sept. 04,...
ROCKAWAY, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced...
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak®...
RESEARCH TRIANGLE PARK, N.C., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing...
GAITHERSBURG, Md., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting...
LONDON, Sept. 4, 2025 /PRNewswire/ -- DayTrading.com, a leading information hub for active traders, has published a new study that shows...
63% believe current age verification methods are too easy to bypass, highlighting the need for smarter, tech-driven solutionsAge-verification technology at...
LINKÖPING, Sweden, Sept. 4, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) reports double order bookings,...